Journal All products are made under Good Manufacturing Practices (GMP) and Food Safety Moderni
1 min read
Like many cannabinoids, cannabinol (CBN) appears to have beneficial effects in experimental models of glaucoma.
November 21, 2022
Read More
2 min read
In vivo studies consistently report anti‐epileptic effects with cannabidivarin (CBDV).
November 18, 2022
Read More
2 min read
CBG (cannabigerol) has shown itself to be of beneficial effect in animal models of Huntington's disease.
November 17, 2022
Read More
2 min read
How well CBD enters the system depends to some extent on what food goes with it.
November 16, 2022
Read More Categories addiction alcohol ALS anorexia antibiotics anxiety autism autism spectrum disorder bioavailibility bioengineering bone cancer brain health brain research breast milk breastfeeding bulimia business case cancer cannabichromene cannabidiol cannabigerol cannabinoid research cannabinoid therapy cannabinoids cannabinol cannabis compounds cannabis purity cannabis regulation cannabis use disorder cannibidivarin cardiovascular CBC CBD CBD creams CBD in animals CBD market CBD oil CBD research CBDA CBDV CBG CBGA CBN cocaine cognition Community Covid-19 dementia depression diabetes drug delivery drug interactions eating disorders endocannabinoids epilepsy eye disease eye injury fibromyalgia pain food glaucoma Gummies Healthy Living Huntington's disease immune system Inaccurate labeling juvenile arthritis methamphetamines multiple sclerosis neurodegenerative diseases neuroprotection nicotine obesity OCD older people online shopping ophthalmology opioids osteoporosis pain palliative care Parkinsonism pharmaceutical cannabinoids psychiataric disorders psychosis PTSD research residual THC safety schizophrenia sex differences side effects sleep synthesis synthetic cannabinoids synthetic CBD THC the endocannabinoid system tinnitus toxicity vascular dementia
